| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/15/2001 | WO2001017516A2 Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48 |
| 03/15/2001 | WO2001017515A1 Degradable polymers |
| 03/15/2001 | WO2001017514A1 Modulation of gene expression by modulating histone acetylation |
| 03/15/2001 | WO2001017513A2 Pharmaceutical composition comprising an insulin sensitizer |
| 03/15/2001 | WO2001017512A2 Combination preparation for initiation of oestrus |
| 03/15/2001 | WO2001017510A1 Agent for stimulating bowel function and method for producing the same |
| 03/15/2001 | WO2001017508A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 03/15/2001 | WO2001017504A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 03/15/2001 | WO2001017501A1 Enzyme inhibitors |
| 03/15/2001 | WO2001017499A1 Skin normalizing agents |
| 03/15/2001 | WO2001017498A1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/15/2001 | WO2001017497A1 Depigmenting compositions |
| 03/15/2001 | WO2001017495A1 Skincare composition against free radicals |
| 03/15/2001 | WO2001017487A1 Chemical peeling agent |
| 03/15/2001 | WO2001017480A2 Methods and compositions for preventing and treating urinary tract disorders |
| 03/15/2001 | WO2001017479A2 Methods and compositions for preventing and treating prostate disorders |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2001017377A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 03/15/2001 | WO2001017374A1 Compositions comprising conjugated linoleic acid (cla) |
| 03/15/2001 | WO2001017367A1 Natural physiologically active substances efficacious against fish parasites and fish feeds containing the substances |
| 03/15/2001 | WO2001017366A1 Improving condition of elderly pets |
| 03/15/2001 | WO2001017364A1 Food product and process for manufacturing same |
| 03/15/2001 | WO2001017349A1 Thrombopoietin mimetics |
| 03/15/2001 | WO2000078779A3 N-pyrazole a2a receptor agonists |
| 03/15/2001 | WO2000075127A8 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 03/15/2001 | WO2000074678A8 Analgesics |
| 03/15/2001 | WO2000071125A3 Pharmaceutical preparation containing the active substance diamorphine and its utilization in a method for treating opiate addiction |
| 03/15/2001 | WO2000071102A3 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 03/15/2001 | WO2000069425A3 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 03/15/2001 | WO2000067741A3 (s,r) formoterol methods and compositions |
| 03/15/2001 | WO2000066614A8 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY |
| 03/15/2001 | WO2000066174A3 Compounds |
| 03/15/2001 | WO2000064468A3 Therapeutic compositions and methods for enhancing angiogenesis |
| 03/15/2001 | WO2000064418A3 Transdermal therapeutic system with neutralized acrylic adhesive patch |
| 03/15/2001 | WO2000061604A3 Pharmaceutical compounds |
| 03/15/2001 | WO2000059469A3 Endodontic fibers and methods of use therefor |
| 03/15/2001 | WO2000053583A8 Inhibitors of protein tyrosine phosphatase |
| 03/15/2001 | WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 03/15/2001 | WO2000049007A8 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
| 03/15/2001 | WO2000047733A9 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 03/15/2001 | WO2000047196A3 Use of statins for treating viral infections |
| 03/15/2001 | WO2000044398A3 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 03/15/2001 | WO2000044358A3 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections |
| 03/15/2001 | WO2000041526B1 Use of s-triazines for treating apicomplexan parasitic infections |
| 03/15/2001 | WO2000024419A8 Methods for enhancing wound healing |
| 03/15/2001 | WO2000013648B1 Method for the preparation of citalopram |
| 03/15/2001 | WO2000010562A8 Physically stable and x-ray amorphous form of hydrochloride ranitidine having an increased anti-ulcer activity and method for producing the same |
| 03/15/2001 | WO1999059996A8 Antitumour 1,5-diazaanthraquinones |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | US20010000039 A compound having a sulfur-nitric oxide group (S-N=O) group as well as a free alcohol or thiol with a half-life of over twelve hours, e.g. S-nitroso-N-acetylpenicillamine; catheter coatings; surface sterilization |
| 03/15/2001 | US20010000038 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 03/15/2001 | US20010000029 A stable gel composition comprising a polyacrylic acid compound, a polyvalent metal component and 75-95 % weight of water user for a covering or laminated sheet to cool bodies to induce sleep |
| 03/15/2001 | US20010000028 A mixture of lecithin, a vitamin B complex, and nutritional antioxidants; accumulation of fats in the liver which can lead to cirrosis |
| 03/15/2001 | DE19943983A1 Cerebral plasticity providing medicament comprising modafinil, useful for improving the rehabilitation of stroke patients |
| 03/15/2001 | DE19943815A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen |
| 03/15/2001 | DE19943708A1 Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New C13-substituted estra-1,3,5 (10) -triene-3-yl-sulfamate, to their preparation and to pharmaceutical compositions containing these compounds, method |
| 03/15/2001 | DE19943639A1 Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften Dicarboxylic acid derivatives with novel pharmaceutical properties |
| 03/15/2001 | DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/15/2001 | DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties |
| 03/15/2001 | DE19943491A1 Verbesserte Komprimate Improved compressed |
| 03/15/2001 | DE19943317C1 Kunststofffolien, insbesondere für die Verwendung in einem dermalen oder transdermalen therapeutischen System und Verfahren zu ihrer Herstellung Plastic films, in particular for use in a dermal or transdermal therapeutic system and method for their preparation |
| 03/15/2001 | DE19943198A1 Phosphatidyl serine-based nutritional supplement and/or therapeutic composition, useful e.g. for treating depression or Alzheimer's disease, containing docosahexaenoic acid component to improve resorption |
| 03/15/2001 | DE19942812A1 Verfahren zur Herstellung von D-(3'-Pyridyl)-alanin Process for the preparation of D- (3'-pyridyl) -alanine |
| 03/15/2001 | DE19942774A1 Zubereitungen zur oralen Aufnahme Preparations for oral administration |
| 03/15/2001 | DE19942474A1 Pyrazolo[4,3-d]pyrimidine Pyrazolo [4,3-d] pyrimidines |
| 03/15/2001 | DE19942365A1 Bulking agent based on three dimensional polymer network useful in stimulation of bowel activity and normalization of bowel evacuation |
| 03/15/2001 | DE19941764A1 Substituierte Acylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika sowie sie enthaltende Medikamente Substituted acylguanidines, processes for their preparation, their use as medicaments or diagnostics and drugs containing them |
| 03/15/2001 | DE19941559A1 Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie Using Bissulfonamiden for the preparation of medicaments for the prophylaxis or treatment of Hyperlipidömie |
| 03/15/2001 | DE19941217A1 Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben Treatment of migraine by administration of alpha-lipoic acid or derivatives thereof |
| 03/15/2001 | DE19940944A1 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms |
| 03/15/2001 | DE19939044A1 Verwendung von Morphinanderivaten als Arzneimittel Use of morphinan derivatives as medicaments |
| 03/15/2001 | DE19937304A1 Verwendung von CGRP-Antagonisten und CGRP-Release-Hemmern zur Bekämpfung menopausaler Hitzewallungen Use of CGRP antagonists and CGRP release inhibitors to combat menopausal hot flashes |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | DE19925073A1 Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung Nucleic acid molecules with specific detection of native PrP c · S · · ·, production and use |
| 03/15/2001 | DE10014639A1 cDNSen mit einer Kodierung von Enzymen zur Fructan-Synthese mit einer Niedertemperatur-Expression sowie Verfahren zu deren Isolierung cDNSen with a coding for enzymes of fructan synthesis with a low-temperature expression as well as methods for their isolation |
| 03/15/2001 | CA2671852A1 Delivery device |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384671A1 Vitronectin receptor antagonists |
| 03/15/2001 | CA2384456A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | CA2384151A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | CA2384101A1 Tyrosine kinase inhibitors |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384051A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | CA2384048A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 03/15/2001 | CA2384028A1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | CA2383998A1 Amino-triazolopyridine derivatives |
| 03/15/2001 | CA2383996A1 Agent for stimulating bowel function and method for producing the same |
| 03/15/2001 | CA2383981A1 Integrin-mediated drug targeting |
| 03/15/2001 | CA2383974A1 Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
| 03/15/2001 | CA2383971A1 Prophylactic and therapeutic medicaments for ophthalmic diseases |
| 03/15/2001 | CA2383946A1 Pharmaceutical composition |
| 03/15/2001 | CA2383932A1 Synthetic vegetal melanins, process for their production and compositions containing thereof |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |